Skip to content

ââ?¬Å? comparison between screening methods (self-sampling versus assisted sampling)"

Awareness, Opinion on Cancer Cervix, Compare the Acceptance of Self Sampling versus Assisted Sampling on hpv Screening and Barriers for hpv vaccination among women in the selected villages of Puducherry

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045714
Enrollment
160
Registered
2022-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: self-sampling method on hpv screening: self-sampling swab will be given and collected as soon as sample is taken by subjects and report will be given within week. Control Intervention1:

Sponsors

Mother Theresa Post Graduate Research Institute Of Health Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Married women aged 25 to 65 years living in selected village of Pondicherry. 2 Should be resident of India 3 Willing to participate in the study 4 No previous hysterectomy 5 Available during the data collection

Exclusion criteria

Exclusion criteria: 1 Not willing to give informed consent. 2 unmarried 3 Pregnancy 4 Having hysterectomy 5 Active bleeding per vagina

Design outcomes

Primary

MeasureTime frame
� Women can find cancer cervix by early detection to get chance to treat before symptoms. � If the cancer is already present, early detection due to screening women can get chance of better survival. � Women screening status will improve. � Women will get chance to know about their own health status. Timepoint: quantitative outcome WILL be assessed after 6 month than for qualitative will be done based on quantitative analysis

Secondary

MeasureTime frame
� Reduce the prevalence of cervical cancer by early detection in selected villages. � Project will provide the awareness regarding cancer cervix and hpv vaccination in selected villages. � Less financial burden will be offered to women and their families as improving health screening of women will reduce the chances of cancer cervix. � The women mortality due to cervical cancer statistic will be reduced by early detection. � Estimate the coverage of HPV vaccine and understand noncompliance factors. � Work as formative research to develop preventive interventional packages based on non-compliance factors of HPV vaccine. � Used to draft health protection scheme for prevention of cervical cancer for state and central government � The women morbidity rate will be improved. � Early identification and preventive treatment of cervical abnormalities. � More women get chance to aware and screened Timepoint: one year

Countries

India

Contacts

Public ContactANKITA JACOB

MOTHER THERESA POST GRADUATE & RESEARCH INSTITUTE OF HEALTH SCIENCES

manju_narayan@rediffmail.com7651893809

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026